Amgen Inc. (AMGN) Q3 2008 Earnings Results

Amgen Beats on EPS, Stock Down 5.03%

Amgen's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by over 5% in reaction, likely due to the lack of revenue details and no forward guidance. Investors may be concerned about the company's future performance amidst market challenges.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.23	N/A	+15.60%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed concerns about market conditions affecting performance. They are prioritizing cost management but did not provide future guidance.

Management highlighted ongoing challenges in the market.

They emphasized a focus on cost management and efficiency.

There was no specific guidance provided for future quarters.

Amgen Beats on EPS, Stock Down 5.03%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Down 5.03%

Key numbers

Management commentary